Position in PHVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,360,965
+$96,580 QoQ
Shares Held
39,357
-12.1% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 124 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,788,615,626 across 151 Biotechnology names. PHVS ranks #125 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
717,440 | $356,373,971 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
293,020 | $182,709,690 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
374,080 | $112,609,302 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
456,331 | $85,461,669 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,159,800 | $65,029,986 | |
| 6 | INSM |
INSMED Inc
|
593,512 | $63,280,249 | |
| 7 | INCY |
Incyte Corp
|
476,874 | $54,058,436 | |
| 8 | MRNA |
Moderna, Inc.
|
679,900 | $47,613,397 |
All Filings in PHVS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,360,965 | 39,357 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,264,385 | 44,757 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,242,006 | 44,757 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,056,807 | 42,357 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $462,123 | 26,257 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $412,234 | 26,257 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $503,346 | 26,257 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $486,279 | 26,257 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||